9 completed, 2 unknown, 1 recruiting, 1 terminated. 13 Phase 2, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Completed 9, Unknown 2, Recruiting 1, Terminated 1 |
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow halofantrine: new trials by email Literature Review of halofantrine trials Research Report on halofantrine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals Recombinant herpes zoster vaccine with low-dose adjuvant, Recombinant herpes zoster vaccine with high-dose adjuvant, Low-dose adjuvant - Herpes Zoster (HZ) | Phase 1 / Phase 2 | Recruiting | Shanghai Institute Of Biological Products | 645 | 2025-04-04 | 2026-01-07 |
| Prophylaxis Against Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy Ondansetron 4mg + dexmedetomidine 0.5 ug/kg + normal saline ., Ondansetron 4mg + dexamethasone 8mg + normal saline. - Postoperative Nausea and Vomiting, Laparoscopic Cholecystectomy | Phase 2 | Unknown | Tanta University | 70 | 2022-09-15 | 2023-08-30 |
| Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX) Herpes zoster vaccination (Shingrix, GSK), Influenza Vaccine (Fluarix Tetra Northern Hemisphere 2021 or 2022, GSK), Placebo - Influenza, Herpes Zoster | Phase 2 | Completed | Radboud University Medical Center | 148 | 2021-09-20 | 2023-06-29 |
| A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children GlaxoSmithKline (GSK) Biologicals' investigational recombinant chimpanzee adenovirus Type 3-vectored Ebola Zaire vaccine (ChAd3-EBO-Z) (GSK3390107A), Nimenrix powder and solvent for solution for injection in pre-filled syringe; Meningococcal group A, C, W-135 and Y conjugate vaccine - Virus Diseases | Phase 2 | Completed | GlaxoSmithKline | 600 | 2015-11-09 | 2018-05-03 |
| A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults GlaxoSmithKline (GSK) Biologicals' investigational recombinant chimpanzee adenovirus Type 3-vectored Ebola Zaire vaccine (ChAd3-EBO-Z) (GSK3390107A), Placebo - Virus Diseases | Phase 2 | Completed | GlaxoSmithKline | 3024 | 2015-07-15 | 2018-01-04 |
| Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis Lapatinib - HER2-positive Gastric Cancer Patients With Liver Metastasis | Phase 2 | Completed | Samsung Medical Center | 32 | 2012-07-09 | 2018-01-17 |
| Sevoflurane Versus Intravenous Anaesthetic Agents in Morbid Obese Patients Sevoflurane, Propofol- Remifentanyl, Propofol, Remifentanyl - Morbid Obesity | Phase 2 / Phase 3 | Unknown | University of Patras | 100 | 2010-04-01 | 2011-01-20 |
| Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults Adjuvanted vaccine against H1N1 influenza virus (GSK) - HIV Infection | Phase 2 | Completed | Oswaldo Cruz Foundation | 450 | 2010-03-01 | 2018-07-18 |
| The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma LMWH, TACE - Hepatocellular Carcinoma | Phase 2 / Phase 3 | Completed | Eastern Hepatobiliary Surgery Hospital | 100 | 2008-12-01 | 2016-04-01 |
| Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy Lapatinib, Radiotherapy (radiation), G.E. Healthcare 1.5T MR, systems revision 12.0 M5 - Head and Neck Cancer, Carcinoma, Squamous Cell | Phase 2 | Terminated | Quynh-Thu Le | 17 | 2007-07-01 | 2017-03-06 |
| Use of N-Acetylcysteine During Liver Procurement N-acetylcystein - Liver Failure, Liver Failure, Acute | Phase 2 | Completed | Azienda Ospedaliera di Padova | 140 | 2006-12-01 | 2013-02-18 |
| Use of Sodium Stibogluconate as a Treatment for Leishmaniasis Sodium Stibogluconate (SSG) - Leishmaniasis | Phase 1 / Phase 2 | Completed | U.S. Army Medical Research and Development Command | 77 | 2004-10-01 | 2020-01-02 |
| Sodium Stibogluconate Treatment of Leishmaniasis Sodium Stibogluconate (SSG) - Leishmaniasis | Phase 2 | Completed | U.S. Army Medical Research and Development Command | 414 | 2002-06-01 | 2021-02-12 |
Carcinoma, Hepatocellular (2) · Herpes Zoster (2) · Leishmaniasis (2) · Liver Diseases (2) · Liver Neoplasms (2) · Virus Diseases (2) · Adenocarcinoma (1) · Carcinoma, Squamous Cell (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Neoplasms (1) · HIV Infections (1) · Head and Neck Neoplasms (1) · Influenza, Human (1) · Liver Failure (1)
GlaxoSmithKline (2) · U.S. Army Medical Research and Development Command (2) · Azienda Ospedaliera di Padova (1) · Eastern Hepatobiliary Surgery Hospital (1) · Oswaldo Cruz Foundation (1) · Quynh-Thu Le (1) · Radboud University Medical Center (1) · Samsung Medical Center (1) · Shanghai Institute Of Biological Products (1) · Tanta University (1) · University of Patras (1)
United States (3) · China (2) · Mali (2) · Senegal (2) · Brazil (1) · Cameroon (1) · Egypt (1) · Greece (1) · Italy (1) · Netherlands (1) · Nigeria (1) · South Korea (1)
Athina Siampalioth, MD (1) · Francesco D'Amico, MD (1) · Glenn Wortmann, MD (1) · Jeeyun Lee, MD, PhD (1) · Kriton Filos, Professor, MD, PhD (1) · Mohamed A. Lotfy, PHD (1) · Quynh-Thu Le (1) · Roseanne Ressner, MD (1) · Shen Feng, MD (1) · Umberto Cillo, MD (1) · Yeqing Tong (1)
PMID 22761759, PMID 22859317, PMID 32199491, PMID 32199492
2014 (1)